Richard T. Penson

Medicine · Health Sciences

67h-index24.1kcitations390works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(199), PARP inhibition in cancer therapy(85), Endometrial and Cervical Cancer Treatments(58), BRCA gene mutations in cancer(37), Palliative Care and End-of-Life Issues(30)

Publications386 total

Association of Multi‐Level LGBTQ+ Stigma and Hypervigilance With Health Outcomes Among LGBTQ+ Cancer Caregivers
UNC Libraries·2026Open Access
Association of Multi‐Level LGBTQ+ Stigma and Hypervigilance With Health Outcomes Among LGBTQ+ Cancer Caregivers
Open MIND·2026
Hypoxia induced VEGF secretion promotes resistance to bispecific T-cell engagers
Signal Transduction and Targeted Therapy·2025· 1 citedOpen Access
Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial
Nature Communications·2025· 1 citedOpen Access
Mechanisms of resistance to anti-MUC16/MMAE antibody-drug conjugate therapy in ovarian cancer
Gynecologic Oncology·2025
Predictive biomarkers for chemotherapy plus bevacizumab in recurrent/metastatic cervical cancer: The NRG Oncology/GOG-0240 National Institutes of Health Cancer Moonshot
Gynecologic Oncology·2025
The PRIMAry point: health-related quality of life (HRQoL).
PubMed·2025
miRNA(s) expression as predictive biomarkers in recurrent/metastatic cervical cancer: The NRG Oncology/GOG-0240 NIH Cancer Moonshot.
Journal of Clinical Oncology·2025
Primary results of a phase 2 study of cisplatin-sensitized radiation therapy and pembrolizumab for unresectable vulvar cancer.
Journal of Clinical Oncology·2025· 5 cited
Phase 2 study of letrozole, abemaciclib, and metformin in estrogen receptor (ER)–positive recurrent endometrial cancer (EC).
Journal of Clinical Oncology·2025· 3 cited
Phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair proficient recurrent or persistent endometrial cancer
Gynecologic Oncology·2025· 1 cited
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer
JCO Precision Oncology·2025· 2 cited
Long-Term Results of a Phase 2 Study of Adjuvant Proton Radiation Therapy for Node-Positive Cancer of the Uterus and Cervix
International Journal of Radiation Oncology*Biology*Physics·2025· 3 cited
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results
Journal of Clinical Oncology·2024· 4 citedOpen Access
Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer
Gynecologic Oncology·2024· 1 citedOpen Access
Serial circulating tumor DNA (ctDNA) sequencing to monitor response and define acquired resistance to letrozole/abemaciclib in endometrial cancer (EC).
Journal of Clinical Oncology·2024· 1 cited
Real-world biomarker testing, treatment patterns and outcomes in a US cohort of patients with advanced ovarian cancer.
Journal of Clinical Oncology·2024
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib
Gynecologic Oncology·2024· 8 citedOpen Access
Data from Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors
2024Open Access
Data from Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors
2024Open Access
page 1 of 20Next →

Frequent Co-authors

Ursula A. Matulonis(20), David M. O’Malley(9), Deborah K. Armstrong(8), Michael V. Seiden(8), Michael Friedländer(7), Jonathan A. Ledermann(7), Jacob Korach(7), Tomasz Huzarski(7), Amit M. Oza(6), Sandro Pignata(6), Robert A. Burger(6), Panagiotis A. Konstantinopoulos(6), David M. Gershenson(6), Éric Pujade-Lauraine(5), Nicoletta Colombo(5), Susana Banerjee(5), Kenji Tamura(5), Gabe S. Sonke(5), Stephen A. Cannistra(5), Larry J. Copeland(5)